Adverse Event Clinical Trials in Shenzhen, Guangdong
2 recruitingShenzhen, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
MelanomaImmune Checkpoint InhibitorImmune-related Adverse Event
Sun Yat-sen University55 enrolled2 locationsNCT07644897
Recruiting
Phase 4
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia
Perioperative Respiratory Adverse EventsHigh-RiskRespiratory Hypersensitivity+2 more
Sun Yat-sen University204 enrolled2 locationsNCT06624696